pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 607 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
teverelix
teverelix [INN]
Prostate Cancer
Antev Ltd
2 catalysts
Phase 2
ONO-4578
Metastatic Colorectal Cancer
Bristol-Myers Squibb Co
1 catalysts
Phase 2
brentuximab vedotin
Adcetris (brentuximab vedotin)
Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy
TubulinTumor necrosis factor receptor superfamily member 8
PFIZER INC
← prev
page 1 of 21
next →
131
Pain89
Neurology1
$PFE
1 catalysts
Phase 2
cadonilimab
Hepatocellular Carcinoma
Programmed cell death protein 1Cytotoxic T-lymphocyte protein 4
Akeso Inc
1 catalysts
Phase 2
dostarlimab
Jemperli (dostarlimab-gxly)
Rectal Cancer
Programmed cell death protein 1
$GSKGSK plc
1 catalysts
Phase 2
emavusertib hydrochloride
Chronic Lymphocytic Leukemia (CLL)
$CRISCURIS INC
1 catalysts
Phase 2
navlimetostat
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
1 catalysts
Phase 2
samuraciclib
samuraciclib [INN]
Breast Cancer
Carrick Therapeutics Ltd
1 catalysts
Phase 2
soficabtagene geleucel
soficabtagene geleucel [INN]
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Wugen Inc
1 catalysts
Phase 2
toripalimab
Loqtorzi (toripalimab-tpzi)
Esophageal Squamous Cell Carcinoma (ESCC)
Programmed cell death protein 1
$CHRSCoherus Oncology, Inc.
1 catalysts
Phase 2
ubidecarenone
ubidecarenone [INN]
Metastatic Adenocarcinoma of The Pancreas
BPGbio Inc
1 catalysts
Phase 2
(atigotatug + nivolumab)
(atigotatug [INN] + nivolumab)
Small-Cell Lung Cancer
Bristol-Myers Squibb Co
0 catalysts
Phase 2
(docetaxel + gemcitabine) SR
(docetaxel + gemcitabine)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
$RLMDRELMADA THERAPEUTICS, INC.
0 catalysts
Phase 2
(nanatinostat + valganciclovir)
(nanatinostat + valganciclovir [INN])
Post-Transplant Lymphoproliferative Disorder
Viracta Therapeutics Inc
0 catalysts
Phase 2
(prednisone + valproate sodium)
(prednisone [INN] + valproate sodium)
Diffuse Large B-Cell Lymphoma
Respiratorius AB
0 catalysts
Phase 2
(senaparib + temozolomide)
(senaparib [INN] + temozolomide)
Small-Cell Lung Cancer
IMPACT Therapeutics Inc
0 catalysts
Phase 2
177Lu-LNC-1011
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Yantai Lannacheng Biotechnology Co Ltd
0 catalysts
Phase 2
7MW-4911
Colorectal Cancer
Mabwell Shanghai Bioscience Co Ltd
0 catalysts
Phase 2
A-2B530
Metastatic Colorectal Cancer
A2 Biotherapeutics Inc
0 catalysts
Phase 2
A-2B543
Cervical Cancer
A2 Biotherapeutics Inc
0 catalysts
Phase 2
A2A-04
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Coiled Therapeutics Plc
0 catalysts
Phase 2
AAA-614
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$NVSNOVARTIS AG
0 catalysts
Phase 2
AB-001
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Artbio Inc
0 catalysts
Phase 2
AB-2100
Metastatic Renal Cell Carcinoma
Arsenal Biosciences Inc
0 catalysts
Phase 2
ABSK-141
Solid Tumor
Abbisko Therapeutics Co Ltd
0 catalysts
Phase 2
ACP-017
Cutaneous Squamous Cell Carcinoma (cSCC)
Ascendis Pharma AS
0 catalysts
Phase 2
ACT-001
Pediatric Diffuse Intrinsic Pontine Glioma
Accendatech Co Ltd
0 catalysts
Phase 2
ADCED-01
Soft Tissue Sarcoma
ADCendo ApS
0 catalysts
Phase 2
ADG-116
Solid Tumor
$ADAGAdagene Inc.
0 catalysts
Phase 2
AFM-24I
Breast Cancer
Affimed GmbH
0 catalysts